Health ❯Medicine ❯Pharmaceuticals ❯Drug Development

Obesity Treatments

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short